CSR vs SRPT · P/E 126, rev $130.9M vs rev $1.13B
Centerspace (CSR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Centerspace (CSR) is a reit - residential company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported CSR revenue for 2026-06-30 was $130.9M. Net income was -$13.9M. CSR currently screens at market cap $1.05B and trailing P/E 126.1.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
CSR currently screens at market cap $1.05B and trailing P/E 126.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the CSR and SRPT stock pages for the full models.
Not investment advice.